Top

Published in:

Open Access 01-08-2007 | Contrast Media

Nephrogenic systemic fibrosis is not exclusively associated with gadodiamide

Authors: Tim Leiner, Christoph U. Herborn, Mathias Goyen

Published in: European Radiology | Issue 8/2007

Excerpt

The subject of nephrogenic systemic fibrosis (NSF), first addressed in the radiological community in this journal a few months ago [1], is a fast-moving topic with new details arising almost every day. …

Thomsen H (2006) Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide. Eur Radiol 16:2619–2621PubMedCrossRef

Cowper SE, Robin HS, Steinberg SM, Su LD, Gupta S, LeBoit PE (2000) Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 356:1000–1001PubMedCrossRef

Cowper SE (2007) Nephrogenic fibrosing dermopathy (NFD/NSF Web site). 2001–2007. Available at http://www.icnfdr.org. Accessed March 22, 2007.

High WA, Ayers RA, Chandler J, Zito G, Cowper SE (2007) Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 56:21–26PubMedCrossRef

Grobner T (2006) Gadolinium—a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21:1104–1108PubMedCrossRef

Collidge TA, Thompson PC, Mark PB, Traynor JP, Jardine A, Morris STW, Simpson K, Roditi G (2007) Gadolinium-enhanced magnetic resonance imaging and nephrogenic systemic fibrosis—a retrospective case-control Study. Radiology (in press)

Marckmann P, Skov L, Rossen K, Dupont A, Damholt MB, Heaf JG, Thomsen HS (2006) Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 17:2359–2362PubMedCrossRef

United States Food and Drug Administration, Rockville, MD, USA. Public Health Advisory. Gadolinium-containing contrast agents for magnetic resonance imaging (MRI): Omniscan, OptiMARK, Magnevist, ProHance and Multihance. Available from URL: http://www.fda.gov/cder/drug/advisory/gadolinium_agents.htm. (Accessed March 22, 2007)

European Society for Magnetic Resonance in Medicine and Biology. Vienna, Austria. Available from URL: http://www.esmrmb.org/index.php?pid=587&SID=5bbbc5f75411bab76e4aee221e8eacdf. (Accessed March 30, 2007)

10.

Idée J-M, Port M, Raynal I, Schaefer M, Le Greneur S, Corot C (2006) Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review. Fundam Clin Pharmacol 20:563–576PubMedCrossRef

11.

Boyd AS, Zic JA, Abraham JL (2007) Gadolinium deposition in nephrogenic fibrosing dermopathy. J Am Acad Dermatol 56:27–30PubMedCrossRef

12.

Kuo PH, Kanal E, Abu-Alfa AK, Cowper SE (2007) Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology 242:647–649PubMed

13.

Sadowski EA, Bennett LK, Chan MR, Wentland AL, Garrett AL, Garret RW, Djamali A (2007) Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 242(3):647–649

14.

GE Healthcare, Buckinghamshire, United Kingdom. GE Healthcare paper on nephrogenic systemic fibrosis, March 2007. Available from URL: http://www.amershamhealth-us.com/omniscan/GE%20Healthcare%20Paper%20On%20Nephrogenic%20Systemic%20Fibrosis.pdf. (Accessed March 30, 2007)

15.

Bayer Schering Pharma AG, Berlin, Germany. NSF/NFD Update. Available from URL: http://www.berleximaging.com/html/magnevist/nsf_nfd.html. (Accessed March 23, 2007)

Title: Nephrogenic systemic fibrosis is not exclusively associated with gadodiamide
Authors: Tim Leiner
Christoph U. Herborn
Mathias Goyen
Publication date: 01-08-2007
Publisher: Springer-Verlag
Published in: European Radiology / Issue 8/2007
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-007-0663-5

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Nephrogenic systemic fibrosis is not exclusively associated with gadodiamide

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 8/2007

Ultrasound in the diagnosis of developmental dysplasia of the hip in newborns. The European approach. A review of methods, accuracy and clinical validity

Acute appendicitis: diagnostic value of nonenhanced CT with selective use of contrast in routine clinical settings

Self-expanding nitinol stents for treatment of infragenicular arteries following unsuccessful balloon angioplasty

Detection of recurrent rectal cancer with CT, MRI and PET/CT

Microbubble ultrasound contrast agents: an update

Intra-osseous meningioma of the orbit: an unusual presentation (2007: 5b)